Digestive System Diseases Terminated Phase 3 Trials for Sorafenib (DB00398)

Also known as: Digestive System Disease

IndicationStatusPhase
DBCOND0033030 (Digestive System Diseases)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01009593Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)Treatment